Yoichi Inada

Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet

Tatsuya Nagasawa, Yoichi Inada, Shigeru Nakano et al. · European Journal of Pharmacology · 2006 · 231 citations

Medicine, Biochemistry, Pharmacology +12

Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARα-mediated redistribution of ABCB4

Junichi Shoda, Yoichi Inada, Atsutoshi Tsuji et al. · Journal of Lipid Research · 2004 · 57 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +4

Bezafibrate regulates the expression and enzyme activity of 11β-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes

Shigeru Nakano, Yoichi Inada, Hiroaki Masuzaki et al. · American Journal of Physiology-Endocrinology and Metabolism · 2006 · 42 citations

Medicine, Endocrinology, Pharmacology +17

Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor‐β1 in a cultured stellate cell line

Shigeru Nakano, Tatsuya Nagasawa, Tomoyuki Ijiro et al. · Hepatology Research · 2008 · 38 citations

Medicine, Biochemistry, Pharmacology +17

CHARACTERIZATION OF CYTOCHROME P450 EXPRESSION IN MURINE EMBRYONIC STEM CELL-DERIVED HEPATIC TISSUE SYSTEM

Masaru Tsutsui, Shinichiro Ogawa, Yoichi Inada et al. · Drug Metabolism and Disposition · 2006 · 36 citations

Medicine, Biochemistry, Pharmacology +15